NBI On Drugs

NBI On Drugs
You won’t recognize the Nasdaq Biotechnology Index (NBI) the next time you see it. It’s undergone a radical change, bulking up to nearly twice its original size by adding 55 more companies to the list. The new Index, which debuted November 24, now consists of 129 firms � and many of the new additions are drug companies (including specialty pharmas and generic drug manufacturers).

Leave a Reply

Your email address will not be published. Required fields are marked *

Get email updates

Enter your email address to subscribe to this blog and receive notifications of new posts by email.